Metabonomic biomarkers for risk factors of chronic kidney disease
Author:
Funder
State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-016-1239-6.pdf
Reference31 articles.
1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150
2. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(suppl 1):S1–S000
3. Kobayashi T, Matsumura Y, Ozawa T et al (2014) Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure. Anal Bioanal Chem 406(5):1365–1376
4. Kazancioğlu R (2013) Risk factors for chronic kidney disease: an update. Kidney Int Suppl 3(4):368–371
5. Shashar M, Francis J, Chitalia V (2015) Thrombosis in the uremic milieu-emerging role of “thrombolome”. Semin Dial 28(2):198–205
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Integrative transcriptomic and proteomic profile revealed inhibition of oxidative phosphorylation and peroxisomes during renal interstitial fibrosis;Journal of Proteomics;2024-04
2. Metabolome evidence of CKDu risks after chronic exposure to simulated Sri Lanka drinking water in zebrafish;Ecotoxicology and Environmental Safety;2024-03
3. The relationship between nutrition screenings and nutritional status determined by malnutrition in hemodialysis patients;The North African Journal of Food and Nutrition Research;2022-11-24
4. Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients;Frontiers in Pharmacology;2022-10-31
5. Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction;Frontiers in Pharmacology;2022-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3